Search results
Billionaires Are Buying These High-Yield Dividend Stocks Left and Right. Should You Follow Their...
The Motley Fool· 6 days agoAre you famous enough for picking great stocks to become a billionaire money manager? The U.S....
Could current COVID vaccines protect against future outbreaks? New study offers hope
Orange County Register· 2 days agoA group of researchers had the future in mind when they asked if current COVID-19 vaccines and...
Experts Predict Rise In COVID-19 Cases: Vaccine Stocks Climb - Moderna (NASDAQ:MRNA)
Benzinga· 3 days agoAccording to a report from NBC News, experts predict a small rise in COVID-19 cases as a newly...
Pfizer wins cancer drug patent case against AstraZeneca
Pharmaceutical Technology via Yahoo Finance· 5 days agoIn a separate development, the Financial Times has reported that the European Patent Office upheld a...
Moderna and Novavax Hope for Early Launch of This Year’s Covid-19 Shots, Despite FDA Delay
Barrons.com· 5 days agoA Novavax spokesperson said that the later meeting date “will not affect Novavax’s ability to...
Iran's new president's link to COVID vaccine
Newsweek· 5 days agoNew interim Iranian President Mohammad Mokhber received scrutiny for his role in the lack of development of a domestic vaccine at the height of the COVID
Vaccine Stocks Rise on Growing Threat of Bird Flu Infections
Zacks· 2 days agoFree Report) and Pfizer (PFE Quick QuotePFE - Free Report) to set up a possible vaccine program aimed at preventing the spread of the H5N1 virus, also known ...
Better Buy: Inovio Pharmaceuticals vs. Novavax
Motley Fool via Yahoo Finance· 3 days agoThe COVID-19 vaccine was worth tens of billions of dollars, but most of it went into the hands of Moderna and Pfizer. Smaller biotechs ...
Century-old vaccine found to protect type 1 diabetics from infectious diseases
Medical Xpress· 3 days agoTwo back-to-back randomized double-blinded placebo-controlled trials found that the BCG vaccine provided continuous protection for nearly the entire COVID
Pfizer to Cut Costs in Multi-Year Effort
The Wall Street Journal· 3 days agoPfizer is launching a multi-year cost reduction program expected to include operational efficiencies, network structure changes, and product portfolio...